Advances in understanding prognosis in myeloma.
Smith D et al. Br J Haematol. 2016 Sep 8. doi: 10.1111/bjh.14304. [Epub ahead of print].

Stem Cell Transplantation In Multiple Myeloma.
Offidani M et al. Curr Cancer Drug Targets. 2016 Sep 19. [Epub ahead of print].

The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modernmultiple myeloma therapy.
Voorhees PM et al. Clin Adv Hematol Oncol. 2016 Sep;14(9):719-728.

Treatment options for relapse after autograft in multiple myeloma – report from an EBMT educational meeting.
Garderet L et al. Leuk Lymphoma. 2016 Sep 21:1-12. [Epub ahead of print].

Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood.
Murata K et al. Clin Biochem. 2016 Sep 21. pii: S0009-9120(16)30312-5. doi: 10.1016/j.clinbiochem.2016.09.015. [Epub ahead of print].

Statins Are Associated With Reduced Mortality in Multiple Myeloma.
Sanfilippo KM et al. J Clin Oncol. 2016 Sep 19. pii: JCO683482. [Epub ahead of print].

Current treatments for renal failure due to multiple myeloma.
Gavriatopoulou M et al. Expert Opin Pharmacother. 2016 Sep 20. [Epub ahead of print].

Carfilzomib therapy improves quality of life in multiple myeloma.
Das M et al. Lancet Oncol. 2016 Sep 15. pii: S1470-2045(16)30450-8. doi: 10.1016/S1470-2045(16)30450-8. [Epub ahead of print].

Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART before the Horse.
Kenderian SS et al. Biol Blood Marrow Transplant. 2016 Sep 13. pii: S1083-8791(16)30328-7. doi: 10.1016/j.bbmt.2016.09.002. [Epub ahead of print].

Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004.
Kuznetsova IS et al. PLoS One. 2016 Sep 15;11(9):e0162710. doi: 10.1371/journal.pone.0162710. eCollection 2016.

Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus.
Hu Q et al. Adv Mater. 2016 Sep 14. doi: 10.1002/adma.201603463. [Epub ahead of print].

Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer.
Shi Q et al. Eur J Cancer. 2016 Sep 9;67:83-90. doi: 10.1016/j.ejca.2016.07.027. [Epub ahead of print].

Excess Weight Tied to Eight More Cancers.
[No authors listed] Cancer Discov. 2016 Sep 12.[Epub ahead of print].

2016 US lymphoid malignancy statistics by World Health Organization subtypes.
Teras LR et al. CA Cancer J Clin. 2016 Sep 12. doi: 10.3322/caac.21357. [Epub ahead of print].

Development of Novel Immunotherapies for Multiple Myeloma.
Al-Hujaily EM et al. Int J Mol Sci. 2016 Sep 8;17(9). pii: E1506. doi: 10.3390/ijms17091506.

Recent Data Supporting Novel Management Strategies for Patients With Multiple Myeloma.
Dimopoulos MA et al. JAMA Oncol. 2016 Sep 1. doi: 10.1001/jamaoncol.2016.3421. [Epub ahead of print].

Multiple myeloma: managing a complex blood cancer.
Dowling M et al. Br J Nurs. 2016 Sep 8;25(16):S18-28. doi: 10.12968/bjon.2016.25.S18.

Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort.
Gu F et al. PLoS One. 2016 Sep 9;11(9):e0161561. doi: 10.1371/journal.pone.0161561. eCollection 2016.

The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
de Mel S et al. Singapore Med J. 2016 Sep 9. doi: 10.11622/smedj.2016150. [Epub ahead of print].

Recent advances in multiple myeloma: a Korean perspective.
Hong J et al. Korean J Intern Med. 2016 Sep;31(5):820-34. doi: 10.3904/kjim.2015.408. Epub 2016 Sep 1.

Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice.
Lee HS et al. Korean J Intern Med. 2016 Sep;31(5):809-19. doi: 10.3904/kjim.2016.110. Epub 2016 Sep 1.

Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach.
Larocca A et al. J Clin Oncol. 2016 Sep 6. pii: JCO686113. [Epub ahead of print].